AbCellera Biologics Inc.
ABCL
Ранг среди акций
#4143
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Цена акции
$11.99
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$3.88B
Изменение (1 день)
1.57%
Изменение (1 год)
104.52%
Страна
CA
Торговля AbCellera Biologics Inc. (ABCL)
Категория
Healthcare
Коэффициент P/S для AbCellera Biologics Inc. (ABCL)
Коэффициент P/S на October 2026 TTM: 57.09
Согласно последним финансовым отчетам и цене акций AbCellera Biologics Inc., текущий коэффициент P/S (TTM) составляет 57.09. В конце 2023 он составлял 43.42.
История P/S для AbCellera Biologics Inc. с 2018 по 2026
Коэффициент P/S в конце каждого года
| Год | P/S | Изменить |
|---|---|---|
| 2026 (TTM) | 57.09 | 90.86% |
| 2024 | 29.91 | -31.12% |
| 2023 | 43.42 | 629.95% |
| 2022 | 5.95 | -43.40% |
| 2021 | 10.51 | -77.40% |
| 2020 | 46.51 | -94.05% |
| 2019 | 781.63 | -22.42% |
| 2018 | 1.01K | 0.00% |
Коэффициент P/S для аналогичных компаний или конкурентов
| Компания | P/S | Разница P/S | Страна |
|---|---|---|---|
| 10.02 | -82.44% |
US
|
|
| 40.55 | -28.96% |
US
|
|
| 3.96 | -93.06% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -82.23% |
NL
|
